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Abstract
Studies exploring the association between pesticide exposure and Parkinson's disease (PD) are
largely limited to rural populations with occupational exposure. We could find no literature
regarding PD occurring after ingestion of a pesticide. We present a case from our clinic of a man
who developed PD following ingestion of a liquid pesticide during a suicide attempt. PD was
diagnosed, and the patient’s symptoms improved following initiation of carbidopa/levodopa.
This case illustrates the potential role of ingested pesticide exposure in provoking and
accelerating the manifestations of PD.
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During the late 1950s and early 1960s, eloquent medical research by Arvid Caarlson (Nobel
Prize 2000) and Oleh Hornikiewicz led to the discovery of dopamine depletion in the striatum
and dopaminergic cell loss in the substantia nigra (SN) in patients with Parkinson's disease (PD)
[1]. Subsequent clinical trials in the 1960s gave levodopa to patients with PD. The administered
levodopa produced significant improvement in the core clinical PD features of tremor,
bradykinesia, rigidity, and postural instability. Levodopa therapy remains our most effective
therapy for PD. The etiology of PD and the cause of cell loss remained unclear. In 1982 arose a
designer drug culture in Northern California where synthetic chemicals were being developed
for recreational use. A compound was developed in a garage laboratory akin to “synthetic
heroin” 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine (MPTP) [2]. This compound was used by
seven individuals who presented with the acute onset of clinically advanced PD. The work by J.
W. Langston found that MPTP caused severe cell loss in the pigmented (dopaminergic) neurons
of the SN producing the PD symptoms which were responsive to levodopa [2]. This discovery led
to animal models of PD which accelerated PD research [3]. Furthermore, an MPTP metabolite
was chemically similar to paraquat (a commonly used herbicide) and this fact led to studies of
PD and pesticide use in agriculture [2]. An increase in prevalence of PD was found to be
associated with pesticide exposure. In 1999, a study of World War II (WWII) veterans who were
twins examined PD [3]. Over the age of 50 years, if one twin developed PD, the monozygotic
and dizygotic twin developed PD at the same 10% rate. However, below age 50 years the
monozygotic twin always developed PD (100%), while the 10% rate occurred in the dizygotic
twin. While genetic predisposition appears to be the most significant risk factor for developing
PD below age 50 years, above that age genetic predisposition interacts with environmental or
other factors. Hence, the expression “genetics loads the gun and the environment pulls the
trigger” [4]. Epidemiological research has suggested that two commercial agrochemicals,
paraquat and maneb, are apparent triggers for PD [5]. Paraquat is typically used during the
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growing process and maneb is applied following harvesting to prevent spoiling. Because the
contribution of pesticides to the evolution of PD has been presumed to be dependent on both
dose and frequency of exposure, a focus on farming/rural communities has emerged. Presently,
we are unaware of literature regarding the ingestion of pesticide and its potential contribution
to developing PD. In this case report, we describe the evolution of PD following an attempted
suicide via the intentional ingestion of pesticides.

Case Presentation
A 65-year-old male with a past medical history significant for major depressive disorder and
generalized anxiety disorder attempted suicide via intentional ingestion of two ounces
of Termidor, a liquid insecticide. He was hospitalized at that time following the abrupt onset of
ataxia, confusion, and seizures. Thereafter, he spent a brief time in a behavioral health facility.
He had noticed an occasional tremor of the left hand before his suicide attempt. During the two
years following hospitalization for pesticide ingestion, he developed slowness of movements
with particularly diminished arm swing (left > right) and diminished facial expression and eye
blinking. He developed softened speech and micrographic handwriting. He developed difficulty
swimming which he had enjoyed as exercise. He developed a prominent resting hand tremor
(left > right). All of these PD features showed marked improvement following the diagnosis of
PD and initiation of carbidopa/levodopa in November 2018. Prior to this suicide attempt, he
had been using alprazolam for many years to manage his generalized anxiety. He had attended
a detoxification program to wean from alprazolam and was successfully transitioned from
alprazolam to a combination of olanzapine (briefly used), bupropion, and clonazepam (also
briefly used) by a psychiatrist. He underwent electroencephalogram (EEG) at that time which
was unremarkable. Neuroimaging at that time included an unremarkable CT brain and an MRI
brain (Figure 1), with white matter chronic microvascular ischemic changes without any
appreciable signal changes in the basal ganglia.
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FIGURE 1: Multiple T2 hyperintense foci can be seen in the
white matter on axial FLAIR consistent with chronic
microvascular ischemic changes.
FLAIR, fluid-attenuated inversion recovery

For his anxiety, he has continued taking one teaspoon of “Kratom” (an herbal opioid agonist
with some stimulant effect) dissolved in water, approximately four times per day. The patient
feels this compound has helped both his anxiety and sleep difficulties. He has tried sertraline
for his depression and buspirone for his anxiety, both of which found to be ineffective. He
continues to do well using carbidopa/levodopa for his PD symptoms.

Discussion
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PD is a progressive neurodegenerative disease that affects movement. The cardinal clinical
features begin insidiously with resting tremors on one side which eventually spread to both
sides. Akinesia is the most significant PD feature with slowing of bodily movement, including
diminished facial expression, eye blinking, and arm swing. A forward stooped posture and
shuffling, narrow-based gait are additional hallmark clinical features. Impaired postural
stability occurs as the disease progresses. The pathologic features are progressive loss of
dopaminergic neurons in the SN with intracellular inclusions called Lewy bodies. The Lewy
bodies contain a protein alpha synuclein. While specific genes have been identified that play a
role in developing PD (LRRK2, PARK7, PINK1, PRKN, SNCA), pesticide exposure has been
implicated as a possible precipitant of disease [6]. The current patient had onset of PD
following the intentional ingestion of a liquid pesticide called Termidor. This agent is a
commonly used termiticide that contains fipronil (5-amino-1-[2,6-dichloro-4-(trimethyl
ethyl)sulfinyl]-1H-pyrazole-3-carbonitrile). First discovered in 1987, this broadly used
insecticide belongs to the phenylpyrazole family and has been approved for use in the United
States since 1996 [7]. Aside from its agricultural use in soil treatment and crop protection,
fipronil is also available for use as the topical applicant (aka Frontline) for dogs and cats to
mitigate flea, tick, and mite infestations. Fipronil disrupts GABA- and glutamate-gated chloride
channels in the central nervous system of insects. This results in blocking inhibitory
neurotransmission that leads to hyperexcitability (at lower doses) followed by paralysis and
death (at higher doses). It is presumed that these adverse effects are limited to insects due to its
high affinity for specific receptor subtypes including GABAA; the binding affinity for this
receptor is far greater in arthropods than in humans. This may account for its reported low risk
for acute toxicity. Furthermore, glutamate-gated chloride channels have only been observed in
invertebrates. In the case of humans, ingestion appears to be followed by rapid and complete
absorption in the GI tract with extensive metabolism to the sulfone derivative followed by
significant enterohepatic recirculation [7]. Neurotoxicity following ingestion is better
understood in insects than in mammals but signs of neurotoxicity following ingestion by
laboratory animals have been observed. These signs included gait abnormalities, tremors,
convulsions, and postural changes including stooped posture [7]. Ingestion by humans was
either inadvertent or secondary to a suicide attempt. Reported signs/symptoms following
human ingestion included headache, generalized or tonic-clonic seizures (our patient had
seizures during the initial hospitalization), paresthesia, pneumonia, and death. Significant
associations between PD incidence and pesticide exposure (e.g. alachlor, broxomy) exist, and
exposure to such chemicals is thought to interrupt the functions of cells in a manner that
parallels the impacts of mutations that are known to cause PD [8]. Individuals exposed to a
variety of agrochemicals have a near 250% increased risk of developing PD when compared to
control populations [9]. While studies regarding the cumulative effect of exposure to
agrochemicals (e.g. inhalation, cutaneous absorption) are well documented, there remain no
reports to date that explore the adverse effects or sequelae that follow inadvertent or
intentional ingestion of insecticides [10]. There does appear to be a propensity for the
development of PD following exposure to agrochemicals in patients with an underlying genetic
predisposition. It is important to note that before ingestion, aside from his chronic anxiety and
depression our patient did describe an occasional resting left-handed tremor. This may have
represented an early sign of PD. However, the rapid progression of PD over the 1.5 to 2 years
following ingestion of Termidor (specifically, fipronil) suggests an accelerated course of PD. In
developing nations, the substance most frequently used in an attempted suicide is an
agricultural pesticide [10]. Still, no reports regarding PD following such suicide attempts were
found.

Conclusions
The association between exposure to agrochemicals and their influence on the development of
PD continues to be explored. This case report presents a unique exposure history with a
solitary, intentional ingestion of pesticide. Most of the literature currently published describes
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a population with known frequency or dose-dependent exposure, e.g. farmers, agricultural
workers, or more simply those residing in rural settings. Notably, our patient reported an
occasional resting tremor of the left hand in the year prior to ingestion. This fact suggests that
his PD was in its early evolution before pesticide ingestion and that this exposure served as a
potentiating factor accelerating the progression of disease.

Additional Information
Disclosures
Human subjects: Consent was obtained by all participants in this study. Conflicts of interest:
In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from
any organization for the submitted work. Financial relationships: All authors have declared
that they have no financial relationships at present or within the previous three years with any
organizations that might have an interest in the submitted work. Other relationships: All
authors have declared that there are no other relationships or activities that could appear to
have influenced the submitted work.

References
1.

2.
3.
4.
5.

6.

7.

8.
9.

10.

Lees AJ, Tolosa E, Olanow CW: Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh
Hornykiewicz, George Cotzias, and Melvin Yahr. Mov Disord. 2015, 30:19-36.
10.1002/mds.26120
Langston JW: The MPTP story. J Parkinsons Dis. 2017, 7:S11-S19. 10.3233/JPD-179006
Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW: Parkinson
disease in twins: an etiologic study. JAMA. 1999, 281:341-346.
Duty S, Jenner P: Animal models of Parkinson's disease: a source of novel treatments and
clues to the cause of the disease. Br J Pharmacol. 2011, 164:1357-1391.
Vaccari C, El Dib R, de Camargo JLV: Paraquat and Parkinson's disease: a systematic review
protocol according to the OHAT approach for hazard identification. Syst Rev. 2017, 6:98.
10.1186/s13643-017-0491-x
Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C: Genetic etiology of Parkinson disease
associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation
update. Hum Mutat. 2010, 31:763-780. 10.1002/humu.21277
Pfister K, Armstrong R: Systemically and cutaneously distributed ectoparasiticides: a review of
the efficacy against ticks and fleas on dogs. Parasit Vectors. 2016, 9:436. 10.1186/s13071-0161719-7
Wan N, Lin G: Parkinson's disease and pesticides exposure: new findings from a
comprehensive study in Nebraska, USA. J Rural Health. 2016, 32:303-313. 10.1111/jrh.12154
ScienceDaily. Study uncovers cause of pesticide exposure, Parkinson's link: Low-level
exposure to the pesticides disrupts cells in a way that mimics the effects of mutations known
to cause Parkinson's disease. (2018). Accessed: July 24, 2020:
http://www.sciencedaily.com/releases/2018/05/180523133158.htm.
Gunnell D, Eddleston M: Suicide by intentional ingestion of pesticides: a continuing tragedy
in developing countries. Int J Epidemiol. 2003, 32:902-909. 10.1093/ije/dyg307

2020 Grossman et al. Cureus 12(7): e9409. DOI 10.7759/cureus.9409

5 of 5

